Dr. Jeff Settleman, Ph.D., Chief Scientific Officer, Oncology Research and Development, Pfizer
Advertisement
Articles by Dr. Jeff Settleman, Ph.D., Chief Scientific Officer, Oncology Research and Development, Pfizer
Advertisement
Latest Updated Articles
- Bispecific antibodies in multiple myeloma: revolutionizing blood cancer immunotherapy
Published: June 21st 2024 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Relacorilant Plus Nab-Paclitaxel Meets OS End Point of ROSELLA Trial in PROC
2
ILUSTRO Trial Signals Role for First-Line Zolbetuximab-Based Triplet for Biomarker-Selected Gastric Cancer
3
FDA Approves Guardant360 as Encorafenib Companion Diagnostic in BRAF V600E-Mutant mCRC
4
INAVO123 Set to Determine Upfront Role of Inavolisib in PIK3CA-Mutant, HR+ Breast Cancer
5